The InXite mobile app (downloadable from the App Store or on Google Play under InXite Data Platform) will help you understand your risk of contracting the coronavirus and many other illnesses and diseases.

Download on the Apple StoreGet it on Google Play

It starts with a simple health risk assessment and health history along with current health issues and medications. Keep a daily record of your health by tracking it on your app and notify your provider if you begin experiencing symptoms. You can even share your health information with the providers you choose with a unique QR code! If you don’t have a healthcare provider, you can find a highly-rated provider right from the app along with recommended resources near you, including telehealth options. Get started on taking control of your health—right from the convenience of your smartphone. InXite is committed to updating you with all the latest coronavirus news as it happens. Stay tuned for further developments.


InXite Takes Covid-19 Very Seriously

Coronavirus—what you need to know

The coronavirus (COVID-19) pandemic is causing increasing concern worldwide. InXite Health Systems is carefully monitoring this situation to provide our clients, patients and employees with the most up-to-date information as it becomes available. Leading researchers from the Centers for Disease Control and Prevention (CDC) provide the most current information on this disease, including announcements from the White House.

Here are some precautions to take:

• Stay home when you are sick (espe­cial­ly if you are expe­ri­enc­ing res­pi­ra­to­ry symp­toms such as fever, cough, short­ness of breath, sore throat, run­ny or stuffy nose, body aches, headaches, chills or fatigue).
• Wash your hands fre­quent­ly with warm, soapy water for at least 20 sec­onds.
• Cov­er your mouth with tis­sues when­ev­er you sneeze, and dis­card used tis­sues in the trash.
• Avoid peo­ple who are sick with res­pi­ra­to­ry symp­toms.
• Clean fre­quent­ly touched sur­faces.

Here are the President’s coronavirus guidelines for America:


• Lis­ten to and fol­low the direc­tions of your STATE AND LOCAL AUTHORITIES
IF YOU FEEL SICK, stay home. Do not go to work. Con­tact your med­ical provider.
IF YOUR CHILDREN ARE SICK, keep them at home. Do not send them to school. Con­tact your med­ical provider.
the entire house­hold at home. Do not go to work. Do not go to school. Con­tact your med­ical provider.
IF YOU ARE AN OLDER PERSON, stay home and away from oth­er peo­ple.
IF YOU ARE A PERSON WITH A SERIOUS UNDERLYING HEALTH CONDITION that can put you at increased risk (for exam­ple, a con­di­tion that impairs your lung or heart func­tion or weak­ens your immune sys­tem), stay home and away from oth­er peo­ple.


Even if you are young, or otherwise healthy, you are at risk and your activities can increase the risk for others. It is critical that you do your part to slow the spread of the coronavirus.

• Work or engage in school­ing from home when­ev­er pos­si­ble.
IF YOU WORK IN A CRITICAL INFRASTRUCTURE INDUSTRY, as defined by the Depart­ment of Home­land Secu­ri­ty, such as health­care ser­vices and phar­ma­ceu­ti­cal and food sup­ply, you have a spe­cial respon­si­bil­i­ty to main­tain your nor­mal work sched­ule. You and your employ­ees should fol­low CDC guid­ance to pro­tect your health a work.• AVOID SOCIAL GATHERINGS in groups of more than 10 peo­ple.
• Avoid eat­ing or drink­ing at bars, restau­rants and food courts—USE DRIVE-THRU, PICKUP OR DELIVERY OPTIONS.
AVOID DISCRETIONARY TRAVEL, shop­ping trips and social vis­its.
DO NOT VISIT nurs­ing homes or retire­ment or long-term care facil­i­ties unless to pro­vide crit­i­cal assis­tance.

o Wash your hands, espe­cial­ly after touch­ing any fre­quent­ly used item or sur­face.
o Avoid touch­ing your face.
o Sneeze or cough into a tis­sue or the inside of your elbow.
o Dis­in­fect fre­quent­ly used items and sur­faces as much as pos­si­ble.

Pres­i­dent Trump expands tele­health ben­e­fits for Medicare ben­e­fi­cia­ries dur­ing COVID-19 out­break

The Trump Admin­is­tra­tion today announced expand­ed Medicare tele­health cov­er­age that will enable ben­e­fi­cia­ries to receive a wider range of health­care ser­vices from their doc­tors with­out hav­ing to trav­el to a health­care facil­i­ty. Begin­ning on March 6, 2020, Medicare—administered by the Cen­ters for Medicare & Med­ic­aid Ser­vices (CMS)—will tem­porar­i­ly pay clin­i­cians to pro­vide tele­health ser­vices for ben­e­fi­cia­ries resid­ing across the entire coun­try. Read the arti­cle in its entire­ty here.

Text mes­sage rumors of a nation­al quar­an­tine are FAKE

There is no nation­al lock­down. The CDC has and will con­tin­ue to post the lat­est guid­ance on

The CDC rec­om­men­da­tions for clean­ing and dis­in­fect­ing your home

Clean­ing of vis­i­bly dirty sur­faces fol­lowed by dis­in­fec­tion is a best prac­tice mea­sure for pre­ven­tion of COVID-19 and oth­er viral res­pi­ra­to­ry ill­ness­es in house­holds and com­mu­ni­ty set­tings. Click here for detailed clean­ing and dis­in­fect­ing prac­tices.

RSS Breaking News 2

RSS Breaking News 3

  • Improv­ing under­stand­ing of and response to info­demics dur­ing pub­lic health emer­gen­cies Feb­ru­ary 23, 2021
    Fol­low­ing the first glob­al infodemi­ol­o­gy con­fer­ence held in July 2020, WHO and part­ners coor­di­nat­ed a joint call for papers  with 5 aca­d­e­m­ic jour­nals rep­re­sent­ing dif­fer­ent sci­en­tif­ic fields, all relat­ed to com­po­nents of the sci­ence behind man­ag­ing info­demics. This week the first of these aca­d­e­m­ic jour­nals pub­lished its spe­cial info­dem­ic fea­ture. The research find­ings con­tribute to fill­ing the knowl­edge gap iden­ti­fied through the WHO pub­lic health research agen­da for man­ag­ing info­demics released ear­li­er this […]
  • No-fault com­pen­sa­tion pro­gramme for COVID-19 vac­cines is a world first Feb­ru­ary 22, 2021
    New pro­gramme makes com­pen­sa­tion avail­able to eli­gi­ble indi­vid­u­als in 92 low- and mid­dle-income coun­tries with­out need to resort to law court­sThis is the first and only glob­al vac­cine injury com­pen­sa­tion mech­a­nismThe pro­gramme is fund­ed by a small levy on each dose sup­port­ed by the Gavi COVAX AMC   The World Health Orga­ni­za­tion (WHO) and Chubb Lim­it­ed (NYSE: […]
  • WHO Direc­tor-Gen­er­al’s state­ment on Tan­za­nia and COVID-19 Feb­ru­ary 20, 2021
    We extend our con­do­lences to our Tan­zan­ian sis­ters and broth­ers on the recent pass­ing of a senior Tan­zan­ian leader as well as the government’s Chief Secretary.In late Jan­u­ary, I joined Dr Mat­shidiso Moeti, the WHO Direc­tor for the African Region, in urg­ing Tan­za­nia to scale pub­lic health mea­sures against COVID-19 and to pre­pare for vac­ci­na­tion. I […]
  • G7 lead­ers com­mit US$ 4.3 bil­lion to finance glob­al equi­table access to tests, treat­ments and vac­cines in 2021 Feb­ru­ary 19, 2021
    The ACT Accel­er­a­tor part­ner­ship wel­comes over US$ 4.3 bil­lion of new invest­ments from the USA, Ger­many, the Euro­pean Com­mis­sion, Japan, and Cana­da to fund the devel­op­ment and equi­table roll­out of the tests, treat­ments and vac­cines need­ed to end the acute phase of the COVID-19 pandemic.Today’s com­mit­ments bring the amount com­mit­ted to date to US$ 10.3 bil­lion, leav­ing a fund­ing gap […]
  • World Wak­ing Up To Vac­cine Equi­ty Feb­ru­ary 19, 2021
    At the halfway point in the World Health Orga­ni­za­tion and Direc­tor-Gen­er­al Tedros Adhanom Ghe­breye­sus’ 100-day chal­lenge, a move­ment of peo­ple and orga­ni­za­tions is now unit­ing togeth­er under the ban­ner of vac­cine equi­ty. WHO wel­comes the new com­mit­ments made by France, Ger­many, the Unit­ed King­dom of Great Britain and North­ern Ire­land and the Unit­ed States of […]
  • State­ment of the Twen­ty-Sev­enth Polio IHR Emer­gency Com­mit­tee Feb­ru­ary 19, 2021
    The twen­ty-sev­enth meet­ing of the Emer­gency Com­mit­tee under the Inter­na­tion­al Health Reg­u­la­tions (2005) (IHR) on the inter­na­tion­al spread of poliovirus was con­vened by the WHO Direc­tor-Gen­er­al on 1 Feb­ru­ary 2021 with com­mit­tee mem­bers and advis­ers attend­ing via video con­fer­ence, sup­port­ed by the WHO Sec­re­tari­at.  The Emer­gency Com­mit­tee reviewed the data on wild poliovirus (WPV1) and cir­cu­lat­ing […]
  • From paper to dig­i­tal path­way: WHO launch­es first ‘SMART Guide­lines’ Feb­ru­ary 18, 2021
    WHO has launched its first SMART Guide­line, a land­mark effort to accel­er­ate the avail­abil­i­ty and impact of WHO health and data rec­om­men­da­tions with­in dig­i­tal sys­tems at the coun­try lev­el, start­ing with ante­na­tal care.What are SMART guidelines?As coun­tries increas­ing­ly invest in dig­i­tal tech­nolo­gies for health sys­tem strength­en­ing, SMART Guide­lines con­sti­tute a prac­ti­cal approach to mak­ing glob­al […]
  • WHO announces updates on new mol­e­c­u­lar assays for the diag­no­sis of tuber­cu­lo­sis (TB) and drug resis­tance Feb­ru­ary 17, 2021
    Sig­nif­i­cant advances to the diag­no­sis of tuber­cu­lo­sis (TB) and drug resis­tance in adults, ado­les­cents and chil­dren are expect­ed, fol­low­ing key updates on new mol­e­c­u­lar assays, announced by the World Health Orga­ni­za­tion (WHO) in a Rapid Com­mu­ni­ca­tion released today.Diagnosis of TB and drug-resis­tant TB remains a chal­lenge with a third of peo­ple with TB and more than a […]
  • COVAX State­ment on WHO Emer­gency Use List­ing for AstraZeneca/Oxford COVID-19 Vac­cine Feb­ru­ary 16, 2021
    The Coali­tion for Epi­dem­ic Pre­pared­ness Inno­va­tions (CEPI), Gavi, the Vac­cine Alliance (Gavi) and the World Health Orga­ni­za­tion (WHO), as co-leads of the COVAX ini­tia­tive for equi­table glob­al access to COVID-19 vac­cines, along­side key deliv­ery part­ner UNICEF, are pleased to wel­come the news that two ver­sions of the AstraZeneca/Oxford COVID-19 vac­cine have been giv­en WHO Emer­gency […]
  • Tae­ni­a­sis: large-scale treat­ment shows inter­est­ing and far-reach­ing results Feb­ru­ary 16, 2021
    A three-year pilot project for the con­trol of tae­ni­a­sis in Mada­gas­car has shown very inter­est­ing and far-reach­ing results. Eli­gi­ble adults and chil­dren aged five and over in 52 vil­lages in the Dis­trict of Antan­i­fot­sy were treat­ed with the med­i­cine praz­i­quan­tel (at a dose of 10 mg/kg). The med­i­cine was well-tol­er­at­ed, with no major side events […]